|
|
|
Insider
Information: |
Sato Vicki L |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,670,897 |
|
Indirect Shares
|
8,084 |
|
|
Direct
Value |
$40,918,225 |
|
|
Indirect Value
|
$3,617,833 |
|
|
Total
Shares |
1,678,981 |
|
|
Total
Value |
$44,536,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
President |
2005-05-11 |
77,233 |
2005-05-11 |
8,084 |
Premium* |
|
Perkinelmer Inc |
PKI |
Director |
2017-02-09 |
29,970 |
2004-04-27 |
0 |
Premium* |
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2006-09-12 |
11,051 |
2006-09-12 |
0 |
Premium* |
|
Borgwarner Inc |
BWA |
Director |
2020-04-29 |
19,823 |
2014-04-30 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-15 |
116,369 |
2017-12-12 |
0 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-06-30 |
1,315,351 |
|
0 |
Premium* |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
101,100 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
227 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 10
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2005-05-11 |
4 |
AS |
$13.17 |
$92,190 |
D/D |
(7,000) |
108,108 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2005-05-11 |
4 |
OE |
$9.50 |
$66,500 |
D/D |
7,000 |
115,108 |
|
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,669,110 |
|
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-05-19 |
4 |
AS |
$43.35 |
$664,601 |
D/D |
(15,174) |
1,653,936 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,374 |
1,657,310 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-06-21 |
4 |
AS |
$46.00 |
$700,515 |
D/D |
(15,174) |
1,642,136 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-08-19 |
4 |
AS |
$44.36 |
$683,611 |
D/D |
(15,174) |
1,611,788 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-09-17 |
4 |
AS |
$52.31 |
$796,301 |
D/D |
(15,174) |
1,596,614 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-10-19 |
4 |
AS |
$39.12 |
$600,314 |
D/D |
(15,174) |
1,581,440 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-11-26 |
4 |
AS |
$36.80 |
$558,403 |
D/D |
(15,174) |
1,566,266 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-12-20 |
4 |
AS |
$51.87 |
$827,485 |
D/D |
(15,174) |
1,551,092 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-01-18 |
4 |
AS |
$37.39 |
$567,385 |
D/D |
(15,173) |
1,535,919 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-04-28 |
4 |
AS |
$20.74 |
$374,424 |
D/D |
(17,915) |
1,518,004 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-05-09 |
4 |
AS |
$20.62 |
$299,835 |
D/D |
(14,541) |
1,503,463 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,405 |
1,509,868 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-05-24 |
4 |
AS |
$23.82 |
$80,369 |
D/D |
(3,374) |
1,506,494 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-07-08 |
4 |
AS |
$28.87 |
$520,694 |
D/D |
(17,915) |
1,470,664 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-08-08 |
4 |
AS |
$30.29 |
$542,685 |
D/D |
(17,915) |
1,452,749 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-09-08 |
4 |
AS |
$21.90 |
$392,335 |
D/D |
(17,915) |
1,434,834 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-10-10 |
4 |
AS |
$20.67 |
$370,278 |
D/D |
(17,915) |
1,416,919 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-11-08 |
4 |
AS |
$27.38 |
$490,549 |
D/D |
(17,915) |
1,399,004 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-12-08 |
4 |
AS |
$25.81 |
$462,366 |
D/D |
(17,915) |
1,381,089 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-01-09 |
4 |
AS |
$25.83 |
$462,784 |
D/D |
(17,915) |
1,363,174 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-02-08 |
4 |
AS |
$28.35 |
$508,343 |
D/D |
(17,915) |
1,345,259 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-03-08 |
4 |
AS |
$22.59 |
$405,062 |
D/D |
(17,935) |
1,327,324 |
0 |
- |
|
227 Records found
|
|
Page 9 of 10 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|